During the past decade, Central Sooner Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Sooner Research" #1 sponsor was "Pfizer" with 2 trials, followed by "Altimmune, Inc." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Q32 Bio Inc." with 1 trials sponsored and "Reistone Biopharma Company Limited" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Sooner Research" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Central Sooner Research" are "Atopic Dermatitis" (1 trials), "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials), "Eosinophilic Esophagitis" (1 trials) and "Hepatitis B, Chronic" (1 trials). Many other conditions were trialed in "Central Sooner Research" in a lesser frequency.

Most popular intervention types in "Central Sooner Research" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrasimod" (2 trials), "ADX-914" (1 trials), "Guselkumab Dose 1" (1 trials) and "Guselkumab Dose 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Sooner Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Central Sooner Research". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Central Sooner Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Sooner Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".